PMC:7033263 / 14538-14864 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T52","span":{"begin":7,"end":15},"obj":"Body_part"},{"id":"T53","span":{"begin":190,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A52","pred":"fma_id","subj":"T52","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A53","pred":"fma_id","subj":"T53","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T34","span":{"begin":190,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T65","span":{"begin":45,"end":64},"obj":"Disease"},{"id":"T66","span":{"begin":55,"end":64},"obj":"Disease"},{"id":"T67","span":{"begin":195,"end":201},"obj":"Disease"},{"id":"T68","span":{"begin":261,"end":269},"obj":"Disease"},{"id":"T69","span":{"begin":283,"end":292},"obj":"Disease"}],"attributes":[{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T102","span":{"begin":100,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T103","span":{"begin":190,"end":194},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T104","span":{"begin":190,"end":194},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T105","span":{"begin":318,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T106","span":{"begin":322,"end":324},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19","span":{"begin":84,"end":99},"obj":"Chemical"},{"id":"T20","span":{"begin":212,"end":227},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T112","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"T113","span":{"begin":203,"end":326},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T25","span":{"begin":7,"end":21},"obj":"Phenotype"}],"attributes":[{"id":"A25","pred":"hp_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"2_test","denotations":[{"id":"32078069-29161116-22841772","span":{"begin":318,"end":320},"obj":"29161116"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"381","span":{"begin":261,"end":269},"obj":"Species"},{"id":"379","span":{"begin":65,"end":73},"obj":"Species"},{"id":"380","span":{"begin":127,"end":135},"obj":"Species"},{"id":"382","span":{"begin":45,"end":64},"obj":"Disease"},{"id":"383","span":{"begin":190,"end":201},"obj":"Disease"},{"id":"384","span":{"begin":247,"end":256},"obj":"Disease"},{"id":"385","span":{"begin":274,"end":292},"obj":"Disease"}],"attributes":[{"id":"A379","pred":"tao:has_database_id","subj":"379","obj":"Tax:9606"},{"id":"A380","pred":"tao:has_database_id","subj":"380","obj":"Tax:9606"},{"id":"A381","pred":"tao:has_database_id","subj":"381","obj":"Tax:694009"},{"id":"A382","pred":"tao:has_database_id","subj":"382","obj":"MESH:C000657245"},{"id":"A383","pred":"tao:has_database_id","subj":"383","obj":"MESH:D055370"},{"id":"A384","pred":"tao:has_database_id","subj":"384","obj":"MESH:D003643"},{"id":"A385","pred":"tao:has_database_id","subj":"385","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"As the cytokine storm was observed in severe 2019-nCoV infection patients, low dose corticosteroids has been used to treat the patients for possible benefit by reducing inflammatory-induced lung injury. However, corticosteroids did not reduce the mortality for SARS-CoV and MERS-CoV infection by WHO interim guidance [34, 35]."}